NCT01380275 2014-09-25Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.National Cancer Center, KoreaPhase 2 Unknown35 enrolled
NCT00003719 2014-01-06Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 2 Unknown27 enrolled